Emergence of Escherichia coli sequence type ST131 carrying both the bla GES-5 and bla CTX-M-15 genes

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2974-2975

  Kim, Juwon ^a   Hong, Seong Geun ^b   Bae, Il Kwon ^a   Kang, Ji Roung ^a   Jeong, Seok Hoon ^a   Lee, Wookeun ^b   Lee, Kyungwon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CTX M 15; BETA LACTAMASE GES 5; CEFEPIME; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CEFOXITIN; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CLAVULANIC ACID PLUS ERTAPENEM; CLAVULANIC ACID PLUS IMIPENEM; CLAVULANIC ACID PLUS MEROPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE SEQUENCE; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; REPLICON; WILD TYPE;

AGED; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; PRESSURE ULCER;

EID: 79956314435     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01703-10     Document Type: Article

References (15)

1. Bae, I. K., et al. 2007. Genetic and biochemical characterization of GES-5, an extended-spectrum class A β-lactamase from Klebsiella pneumoniae. Diagn. Microbiol. Infect. Dis. 58:465-468. (Pubitemid 47208536)
2. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.
3. Bermudes, H., et al. 1999. Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived β-lactamase in a clinical isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 43:1657-1661. (Pubitemid 29331243)
4. Bogaerts, P., et al. 2010. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob. Agents Chemother. 54:4872-4878.
5. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Dhanji, H., et al. 2011. Molecular epidemiology of fluoroquinolone- resistant ST131 Escherichia coli producing CTX-M extended-spectrum β-lactamases in nursing homes in Belfast, UK. J. Antimicrob. Chemother. 66:297-303.
7. Lee, K., et al. 2010. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J. Microbiol. Methods 83:149-152.
8. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629. (Pubitemid 37259767)
9. Mammeri, H., L. Poirel, N. Mangeney, and P. Nordmann. 2003. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob. Agents Chemother. 47:1536-1542.
10. Oteo, J., M. Pérez-Vázquez, and J. Campos. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
11. Ryoo, N. H., et al. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56:698-702. (Pubitemid 41487771)
12. Sirot, D. L., et al. 1992. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob. Agents Chemother. 36:1677-1681.
13. Villa, L., A. García-Fernández, D. Fortini, and A. Carattoli. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529.
14. Vourli, S., et al. 2004. Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 15:209-213.
15. Walther-Rasmussen, J., and N. Høiby. 2007. Class A carbapenemases. J. Antimicrob. Chemother. 60:470-482.